CRSP CRISPR Therapeutics AG | CH0334081137
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 162.796.710 | 40.110.500 | 305.87% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -3,89 | -4,88 | 20.31% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 19 | 20 | 5.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |